Page 100 - Read Online

aneurysms: a study using the free radical scavenger edaravone and 62. Matsumori A, Nunokawa Y, Sasayama S. Nifedipine inhibits activation
p47phox(‑/‑) mice. Lab Invest 2009;89:730‑41. of transcription factor NF‑kappaB. Life Sci 2000;67:2655‑61.
45. Aoki T, Narumiya S. Prostaglandins and chronic inflammation. 63. Yamagishi S, Inagaki Y, Abe R, Kikuchi S, Sasaki N, Takeuchi M.
Trends Pharmacol Sci 2012;33:304‑11. Nifedipine inhibits apoptotic cell death of cultured endothelial
46. Alfano JM, Kolega J, Natarajan SK, Xiang J, Paluch RA, Levy EI, cells induced by tumor necrosis factor‑alpha. Drugs Exp Clin Res
Siddiqui AH, Meng H. Intracranial aneurysms occur more frequently 2003;29:141‑5.
at bifurcation sites that typically experience higher hemodynamic 64. Yamagishi S, Inagaki Y, Kikuchi S. Nifedipine inhibits tumor
stresses. Neurosurgery 2013;73:497‑505. necrosis factor‑alpha‑induced monocyte chemoattractant protein‑1
47. Metaxa E, Tremmel M, Natarajan SK, Xiang J, Paluch RA, overexpression by blocking NADPH oxidase‑mediated reactive
Mandelbaum M, Siddiqui AH, Kolega J, Mocco J, Meng H. oxygen species generation. Drugs Exp Clin Res 2003;29:147‑52.
Characterization of critical hemodynamics contributing to 65. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an
aneurysmal remodeling at the basilar terminus in a rabbit model. overview. Methods Mol Biol 2006;315:13‑34.
Stroke 2010;41:1774‑82. 66. Liu J, Divoux A, Sun J, Zhang J, Clément K, Glickman JN,
48. Boussel L, Rayz V, McCulloch C, Martin A, Acevedo‑Bolton G, Sukhova GK, Wolters PJ, Du J, Gorgun CZ, Doria A, Libby P,
Lawton M, Higashida R, Smith WS, Young WL, Saloner D. Blumberg RS, Kahn BB, Hotamisligil GS, Shi GP. Genetic deficiency
Aneurysm growth occurs at region of low wall shear stress: and pharmacological stabilization of mast cells reduce diet‑induced
patient‑specific correlation of hemodynamics and growth in a obesity and diabetes in mice. Nat Med 2009;15:940‑5.
longitudinal study. Stroke 2008;39:2997‑3002. 67. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P,
49. Tanoue T, Tateshima S, Villablanca JP, Viñuela F, Tanishita K. Wall MacFarlane LA, Mallen‑St Clair J, Shi GP. Mast cells promote
shear stress distribution inside growing cerebral aneurysm. AJNR atherosclerosis by releasing proinflammatory cytokines. Nat Med
Am J Neuroradiol 2011;32:1732‑7. 2007;13:719‑24.
50. Aoki T, Kataoka H, Ishibashi R, Nakagami H, Nozaki K, Morishita R, 68. Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P,
Hashimoto N. Pitavastatin suppresses formation and progression of Sun C, Zhang Y, Liu J, Ennis TL, Knispel R, Xiong W, Thompson RW,
cerebral aneurysms through inhibition of the nuclear factor kappaB Baxter BT, Shi GP. Mast cells modulate the pathogenesis of
pathway. Neurosurgery 2009;64:357‑65. elastase‑induced abdominal aortic aneurysms in mice. J Clin Invest
51. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Simvastatin 2007;117:3359‑68.
suppresses the progression of experimentally induced cerebral 69. Sun J, Zhang J, Lindholt JS, Sukhova GK, Liu J, He A, Abrink M,
aneurysms in rats. Stroke 2008;39:1276‑85. Pejler G, Stevens RL, Thompson RW, Ennis TL, Gurish MF, Libby P,
52. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Nifedipine Shi GP. Critical role of mast cell chymase in mouse abdominal aortic
inhibits the progression of an experimentally induced cerebral aneurysm formation. Circulation 2009;120:973‑82.
aneurysm in rats with associated down‑regulation of NF‑kappa B 70. Xu JM, Shi GP. Emerging role of mast cells and macrophages in
transcriptional activity. Curr Neurovasc Res 2008;5:37‑45. cardiovascular and metabolic diseases. Endocr Rev 2012;33:71‑108.
53. Ishibashi R, Aoki T, Nishimura M, Hashimoto N, Miyamoto S. 71. Yoshimura Y, Murakami Y, Saitoh M, Yokoi T, Aoki T, Miura K,
Contribution of mast cells to cerebral aneurysm formation. Curr Ueshima H, Nozaki K. Statin use and risk of cerebral aneurysm
Neurovasc Res 2010;7:113‑24. rupture: a hospital‑based case‑control study in Japan. J Stroke
54. Ishibashi R, Aoki T, Nishimura M, Miyamoto S. Imidapril inhibits Cerebrovasc Dis 2014;23:343‑8.
cerebral aneurysm formation in an angiotensin‑converting 72. Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano JM.
enzyme‑independent and matrix metalloproteinase‑9‑dependent Smoking and the risk of hemorrhagic stroke in men. Stroke
manner. Neurosurgery 2012;70:722‑30. 2003;34:1151‑5.
55. Kimura N, Shimizu H, Eldawoody H, Nakayama T, Saito A, 73. Sandvei MS, Romundstad PR, Müller TB, Vatten L, Vik A. Risk factors
Tominaga T, Takahashi A. Effect of olmesartan and pravastatin for aneurysmal subarachnoid hemorrhage in a prospective population
on experimental cerebral aneurysms in rats. Brain Res study: the HUNT study in Norway. Stroke 2009;40:1958‑62.
2010;1322:144‑52. 74. Hasan DM, Mahaney KB, Brown RD Jr, Meissner I, Piepgras DG,
56. Tada Y, Kitazato KT, Tamura T, Yagi K, Shimada K, Kinouchi T, Huston J, Capuano AW, Torner JC. Aspirin as a promising agent
Satomi J, Nagahiro S. Role of mineralocorticoid receptor for decreasing incidence of cerebral aneurysm rupture. Stroke
on experimental cerebral aneurysms in rats. Hypertension 2011;42:3156‑62.
2009;54:552‑7. 75. Gross BA, Rosalind Lai PM, Frerichs KU, Du R. Aspirin and
57. Makino H, Tada Y, Wada K, Liang EI, Chang M, Mobashery S, aneurysmal subarachnoid hemorrhage. World Neurosurg
Kanematsu Y, Kurihara C, Palova E, Kanematsu M, Kitazato K, 2014;82:1127‑30.
Hashimoto T. Pharmacological stabilization of intracranial 76. Garbe E, Kreisel SH, Behr S. Risk of subarachnoid hemorrhage and
aneurysms in mice: a feasibility study. Stroke 2012;43:2450‑6. early case fatality associated with outpatient antithrombotic drug
58. Yagi K, Tada Y, Kitazato KT, Tamura T, Satomi J, Nagahiro S. Ibudilast use. Stroke 2013;44:2422‑6.
inhibits cerebral aneurysms by down‑regulating inflammation‑related 77. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P,
molecules in the vascular wall of rats. Neurosurgery 2010;66:551‑9. Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular risk
59. Blum A, Shamburek R. The pleiotropic effects of statins on associated with celecoxib in a clinical trial for colorectal adenoma
endothelial function, vascular inflammation, immunomodulation prevention. N Engl J Med 2005;352:1071‑80.
and thrombogenesis. Atherosclerosis 2009;203:325‑30.
60. Shovman O, Levy Y, Gilburd B, Shoenfeld Y. Antiinflammatory
and immunomodulatory properties of statins. Immunol Res Cite this article as: Aoki T. Inflammation mediates the pathogenesis
of cerebral aneurysm and becomes therapeutic target. Neuroimmunol
2002;25:271‑85. Neuroinflammation 2015;2(2):86-92.
61. Bellosta S, Bernini F, Ferri N, Quarato P, Canavesi M, Arnaboldi L, Source of Support: Nil. Conflict of Interest: No.
Fumagalli R, Paoletti R, Corsini A. Direct vascular effects of HMG‑CoA
reductase inhibitors. Atherosclerosis 1998;137 Suppl: S101‑9. Received: 26-06-2014; Accepted: 01-09-2014

92 Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015